x
Filter:
Filters applied
- Concise Reviews for Primary-Care Physicians
- proton pump inhibitorRemove proton pump inhibitor filter
- 2017 - 2022Remove 2017 - 2022 filter
Concise Reviews for Primary-Care Physicians
2 Results
- Concise review
Microscopic Colitis: A Concise Review for Clinicians
Mayo Clinic ProceedingsVol. 96Issue 5p1302–1308Published in issue: May, 2021- June Tome
- Amrit K. Kamboj
- Darrell S. Pardi
Cited in Scopus: 3Microscopic colitis (MC) is an inflammatory disease of the colon and a common cause of chronic watery diarrhea, predominantly in older patients. Microscopic colitis encompasses 2 different subtypes, lymphocytic colitis and collagenous colitis. The colon typically appears normal endoscopically in MC, and the diagnosis requires histologic evaluation. Whereas recent studies suggest that the incidence of MC has plateaued, given the aging of the population, the prevalence of MC will likely increase. Risk factors for MC include increasing age; female sex; presence of other autoimmune diseases; and possibly use of certain medications, including proton pump inhibitors, nonsteroidal anti-inflammatory drugs, selective serotonin reuptake inhibitors, and statins. - Concise review for clinicians
Proton Pump Inhibitors: Review of Emerging Concerns
Mayo Clinic ProceedingsVol. 93Issue 2p240–246Published in issue: February, 2018- Avinash K. Nehra
- Jeffrey A. Alexander
- Conor G. Loftus
- Vandana Nehra
Cited in Scopus: 128First introduced in 1989, proton pump inhibitors (PPIs) are among the most widely utilized medications worldwide, both in the ambulatory and inpatient clinical settings. The PPIs are currently approved by the US Food and Drug Administration for the management of a variety of gastrointestinal disorders including symptomatic peptic ulcer disease, gastroesophageal reflux disease, and nonulcer dyspepsia as well as for prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy.